Jiangxi Synergy Pharmaceutical (300636.SZ): The active pharmaceutical ingredient Agomelatine complies with drug GMP.

Jiangxi Synergy Pharmaceutical (300636.SZ) announced that the company has recently received a "Notice of Results of Drug GMP Compliance Inspection" from the Jiangxi Provincial Drug Administration. The company has been informed that after on-site inspection and comprehensive assessment, the active pharmaceutical ingredient Agomelatine complies with drug GMP standards. Agomelatine is used for the treatment of adult depression.